Robert Ratts Email and Phone Number

● Designs and executes decisive research and development projects: enabling phase I clinical trials.● Conducts mouse immunogenicity studies. o Demonstrated long lasting T cell responses● DNA construct generation: artfully generated and validated plasmids, bacmids and viral vector vaccines.● Expertly generated gene inducible expression systems. o Facilitating the development of a complementation titer assay.● Designed assays to characterize vaccine candidates for… Show more ● Designs and executes decisive research and development projects: enabling phase I clinical trials.● Conducts mouse immunogenicity studies. o Demonstrated long lasting T cell responses● DNA construct generation: artfully generated and validated plasmids, bacmids and viral vector vaccines.● Expertly generated gene inducible expression systems. o Facilitating the development of a complementation titer assay.● Designed assays to characterize vaccine candidates for phase I clinical trials.● Production cell line: Established and validated a telomerized cell line suitable for vaccine production or further genetic modifications. Show less

● Designed and generated novel biological materials. o Generated innovative vectors in support of company objectives. o Expertly generated novel gene inducible expression systems.● Expertly designed and executed experiments in support of company goals. o Generated key data for successful grant application.● Conducted mouse immunogenicity studies. o Successfully established mouse model system. o Demonstrated vaccine protection against tumor challenge.… Show more ● Designed and generated novel biological materials. o Generated innovative vectors in support of company objectives. o Expertly generated novel gene inducible expression systems.● Expertly designed and executed experiments in support of company goals. o Generated key data for successful grant application.● Conducted mouse immunogenicity studies. o Successfully established mouse model system. o Demonstrated vaccine protection against tumor challenge. o Demonstrated vaccine therapeutic ability against established tumors. o Expertly designed multi-parameter flow cytometric panels. Show less

● Developed unprecedented small animal model to test viral vectors.● Demonstrated cellular immune response against viral vectors.● Developed original bacterial complementing system for production.

● Demonstrated in the event of periodic lymphocyte loss young donors rely more on thymic output to maintain lymphocyte levels while middle aged donors rely more on peripheral expansion.